Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major
- PMID: 15707464
- DOI: 10.1111/j.1742-1241.2005.00358.x
Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major
Abstract
In this study, bone formation markers (bone-specific alkaline phosphatase and osteocalcin) and bone resorption markers (pyridinoline and deoxypyridinoline) were analysed. Bone formation, as evidenced by the levels of serum alkaline phosphatase and osteocalcin, did not appear to be impaired, while bone resorption was grossly increased in all patient groups. The decrease of bone mineral density values was more prominent in the lumbar spine, thus making this site particularly interesting for such studies. The patients had significantly lower femoral neck and lumbar spine bone mineral density when compared with control (all p <0.001). Our conclusion is that, in spite of the severe bone destruction that occurs in thalassaemia major, the fact that bone formation remains intact calls for a more intensive treatment.
Similar articles
-
Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.Arch Gynecol Obstet. 2006 Jun;274(3):133-7. doi: 10.1007/s00404-006-0148-9. Epub 2006 Mar 11. Arch Gynecol Obstet. 2006. PMID: 16532321
-
Association of immune function with bone mineral density and biochemical markers of bone turnover in patients with anklylosing spondylitis.Int J Clin Pract. 2003 Oct;57(8):681-5. Int J Clin Pract. 2003. PMID: 14627178
-
Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):67-71. doi: 10.1016/j.ejogrb.2005.06.025. Epub 2005 Jul 26. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16051419
-
[Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].Tunis Med. 2006 Nov;84(11):751-7. Tunis Med. 2006. PMID: 17294906 Review. French.
-
Biomarkers of bone health and osteoporosis risk.Proc Nutr Soc. 2008 May;67(2):157-62. doi: 10.1017/S002966510800699X. Proc Nutr Soc. 2008. PMID: 18412989 Review.
Cited by
-
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients.BMC Res Notes. 2018 Jul 31;11(1):534. doi: 10.1186/s13104-018-3616-y. BMC Res Notes. 2018. PMID: 30064480 Free PMC article.
-
Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt.Int J Hematol Oncol Stem Cell Res. 2013;7(4):10-4. Int J Hematol Oncol Stem Cell Res. 2013. PMID: 24505537 Free PMC article.
-
Evaluation of Glutathione-S-Transferase P1 Polymorphism and its Relation to Bone Mineral Density in Egyptian Children and Adolescents with Beta-Thalassemia Major.Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016004. doi: 10.4084/MJHID.2016.004. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 26740865 Free PMC article.
-
Association between serum ferritin and hemoglobin levels and bone health in Korean adolescents: A nationwide population-based study.Medicine (Baltimore). 2017 Dec;96(51):e9403. doi: 10.1097/MD.0000000000009403. Medicine (Baltimore). 2017. PMID: 29390554 Free PMC article.
-
Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/β-catenin signaling pathway in alveolar bone of ovariectomized rats.J Huazhong Univ Sci Technolog Med Sci. 2014 Feb;34(1):114-119. doi: 10.1007/s11596-014-1241-0. Epub 2014 Feb 6. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 24496689
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical